PMID: 25953825
doi: 10.3389/fendo.2025.1551126 Received 24 December 2024 Accepted 31 March 2025 Published 17 April 2025 Volume 16 - 2025 Edited by Michio Kitajima, Takagi Hospital, Japan Reviewed by Long Bai, Zhejiang University, China Kequan Lin, Zhejiang University, China Updates Copyright 2025 Han, Xu, Yuan, Wen, Yang, Han and Zhang
When administered under clinician supervision with medical-grade product, TB-500 has a strong safety record
For Ozempic users experiencing widespread joint discomfort, multiple minor injuries, or general recovery challenges, TB-500's systemic distribution may prove advantageous
Your provider will determine what baseline testing is appropriate for your selected protocol at the initial consultation
It is used as a cosmetic raw material in skincare and personal care formulations